Zhejiang HISUN Biomaterials Co. Ltd. A (688203) — Capital Reinvestment Ratio

Latest as of December 2024: 7.55x

Zhejiang HISUN Biomaterials Co. Ltd. A (688203) has a Capital Reinvestment Ratio of 7.55x as of December 2024, meaning it reinvests 8% of its operating cash flow (CN¥38.84 Million) in capital expenditures (CN¥293.18 Million). See debt-free asset ratio of Zhejiang HISUN Biomaterials Co. Ltd. A to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

7.55x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥38.84 Million
CNY

Capital Expenditures

CN¥293.18 Million
CNY

Data as of

Dec 2024
Most recent filing

Zhejiang HISUN Biomaterials Co. Ltd. A Capital Reinvestment Ratio (2020–2024)

This chart tracks Zhejiang HISUN Biomaterials Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods. Check Zhejiang HISUN Biomaterials Co. Ltd. A cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)

Year-by-year Capital Reinvestment Ratio for Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024. For live market cap and broader valuation context, see market cap of Zhejiang HISUN Biomaterials Co. Ltd. A.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 7.55x CN¥38.84 Million CN¥293.18 Million ▲ +474.8%
2023 1.31x CN¥163.03 Million CN¥214.11 Million ▼ -20.6%
2022 1.65x CN¥136.15 Million CN¥225.27 Million ▼ -61.9%
2021 4.35x CN¥71.18 Million CN¥309.44 Million ▼ -37.1%
2020 6.91x CN¥28.66 Million CN¥198.08 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow